• OPEN AN ACCOUNT
Indian Indices
Sensex
83,576.24 -604.72
( -0.72%)
Global Indices
Nasdaq
49,277.91 260.82
(0.53%)
Dow Jones
6,942.18 0.25
(0.00%)
Hang Seng
51,918.01 800.75
(1.57%)
Nikkei 225
10,051.56 3.35
(0.03%)
Forex
USD-INR
89.93 -0.23
(-0.25%)
EUR-INR
105.10 -0.46
(-0.44%)
GBP-INR
121.29 -0.65
(-0.53%)
JPY-INR
0.57 0.00
(-0.31%)

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543998
INE0JWS01017
58.4359033
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VALIANTLAB
56.14
384.21
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

ntpc ltd
NTPC commissions full 23 MW capacity of Solapur Solar Project
Dec 26,2025
The remaining 13 MW was declared commercially operational effective 25 December 2025, taking the Solapur Solar PV Project to its full 23 MW capacity. Following this, NTPC’s total installed capacity increased to 60,796 MW on a standalone basis and 85,623 MW on a group basis, the company said.

NTPC is India's largest energy conglomerate. It has a presence in the entire value chain of the power generation business.

The company’s consolidated net profit declined 3.9% to Rs 5,066.78 crore on a 0.2% increase in net sales to Rs 44,785.82 crore in Q2 FY26 over Q2 FY25.

Shares of NTPC rose 0.90% to Rs 325.50 on the BSE.